|Articles|September 2, 2014
Applied Clinical Trials Editorial Advisory Board and Clinical Trials Professionals Discuss Importance of DIA
Advertisement
Nancy Dreyer, PhD, MPH, FISPe, discusses the importance of DIA to the industry.
Stewart Geary, MD, discusses how global drug development benefits from DIA.
Michael R. Hamrell, PhD, discusses the impact of DIA on professional development.
Moe Alsumidae discusses how DIA's neutral platform grows industry collaboration and communication.
Tim Callahan, PhD, discusses the scientific benefit of DIA
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
2
AI-Driven Clinical Trial Recruitment and Design
3
Why Clinical Trials Need an Execution Architecture Before AI Can Deliver: Q&A with Abraham Gutman, AG Mednet
4
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
5